Stay updated on Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the page. This represents a maintenance/version update rather than a change to substantive content.
    Difference
    0.0%
    Check dated 2026-08-11T22:49:20.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    IPD sharing information was added to the study page, including an IPD Sharing URL and plan description. The update also introduces IPD sharing access criteria and related policy language, clarifying the availability of de-identified participant data to qualified researchers.
    Difference
    0.5%
    Check dated 2026-08-04T22:31:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new build of the platform. There is no visible change to the study details or other content presented to users.
    Difference
    0.0%
    Check dated 2026-07-21T13:53:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.0 tag. This signals an update to the page's template or content without changing the trial information.
    Difference
    0.0%
    Check dated 2026-06-30T02:40:37.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Enrollment status updated to 'No longer looking for participants', and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention / Treatment heading was reformatted to 'Intervention/Treatment', and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T22:11:38.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating an administrative update to the study record rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-06-08T18:06:45.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.